News and Analysis

ImmunoScape nabs $11m

ImmunoScape, a biotech firm focused on the human immune system, has raised $11 million in funding.

-

ImmunoScape, a biotech firm focused on the human immune system, has raised $11 million in funding. Anzu Partners led the round with participation from University of Tokyo Edge Capital and NPR Holdings.

Source: Press Release